Armata Pharmaceuticals
ARMP
15 hedge funds and large institutions have $1.02M invested in Armata Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
73% less capital invested
Capital invested by funds: $3.77M → $1.02M (-$2.76M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$886K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$213K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.8K |
| 4 |
Renaissance Technologies
New York
|
+$47.1K |
| 5 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
+$38.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
-$2.41M |
| 2 |
TJHA
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
|
-$2K |
| 3 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$1.37K |
ARMP Hedge Fund Activity: Q4 2016 in Review
15 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q4 2016, worth a combined $1.02M — down 73% from $3.77M a quarter earlier.
Fund positioning in ARMP was balanced in Q4 2016: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $886K. The largest seller was Third Security, exiting entirely with an estimated $2.41M sold.
- 15 institutional investors held Armata Pharmaceuticals (ARMP) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $1.02M of Armata Pharmaceuticals stock for Q4 2016, down 73% quarter-over-quarter.
- 4 funds opened new Armata Pharmaceuticals positions in Q4 2016 and 4 closed out, a net change of 0 holders.
- The largest Armata Pharmaceuticals buyer in Q4 2016 was Sabby Management, an estimated $886K added.
- The largest Armata Pharmaceuticals seller in Q4 2016 was Third Security, an estimated $2.41M sold.
Based on aggregated 13F filings for Q4 2016.